Financhill
Sell
44

RVMD Quote, Financials, Valuation and Earnings

Last price:
$38.01
Seasonality move :
4.95%
Day range:
$37.85 - $38.47
52-week range:
$29.17 - $62.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.41x
Volume:
1.4M
Avg. volume:
2.7M
1-year change:
-12.3%
Market cap:
$7.1B
Revenue:
$11.6M
EPS (TTM):
-$4.00

Earnings Data

Next earnings date for RVMD
Aug 07
2025
Most recent earnings per share
-$1.13
Missed by $0.07
(May 7/2025)
Consensus Estimate
-$1.06
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RVMD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $30.6M -- -- -$1.18 --
08/07/2025 Q2 $30.6M -- -- -$1.12 --
05/07/2025 Q1 -- -- -$1.13 -$1.06 -$0.07
02/26/2025 Q4 $346.2K -- -$1.12 -$0.96 -$0.16
11/06/2024 Q3 $346.2K -- -$0.94 -$0.88 -$0.06
08/07/2024 Q2 $807.7K -- -$0.81 -$0.76 -$0.05
05/08/2024 Q1 $674.2K -- -$0.70 -$0.72 $0.02
02/26/2024 Q4 $1.2M $742K -$1.21 -$0.88 -$0.33
11/06/2023 Q3 -- -- -$0.99 -$1.00 $0.01
08/08/2023 Q2 -- -- -$0.92 -$0.82 -$0.10
05/08/2023 Q1 -- -- -$0.72 -$0.80 $0.08
02/27/2023 Q4 -- -- -$0.63 -$0.81 $0.18
11/07/2022 Q3 -- -- -$0.87 -$0.85 -$0.02
08/09/2022 Q2 -- -- -$0.82 -$0.84 $0.02
05/09/2022 Q1 -- -- -$0.78 -$0.77 -$0.01
02/28/2022 Q4 -- -- -$0.71 -$0.64 -$0.07
11/10/2021 Q3 -- -- -$0.72 -$0.62 -$0.10
08/11/2021 Q2 -- -- -$0.60 -$0.56 -$0.04
05/10/2021 Q1 -- -- -$0.53 -$0.52 -$0.01
03/02/2021 Q4 -- -- -$0.52 -$0.43 -$0.09
11/12/2020 Q3 -- -- -$0.42 -$0.40 -$0.02
08/10/2020 Q2 -- -- -$0.46 -$0.37 -$0.09
05/14/2020 Q1 -- -- -$0.74 -$0.36 -$0.38
12/31/2019 Q4 -- -- -$0.36 -$0.62 $0.26
09/30/2019 Q3 -- -- -$0.47 -- --
06/30/2019 Q2 -- -- -$0.36 -- --
03/31/2019 Q1 -- -- -$0.35 -- --
12/31/2018 Q4 -- -- -$0.38 -- --

Revolution Medicines Earnings Questions

  • How Much did Revolution Medicines Generate in Revenue Last Quarter?

    Revolution Medicines reported -- worth of top line sales in its most recent quarter.

  • Did Revolution Medicines Beat Earnings Last Quarter?

    Revolution Medicines announced earnings per share of -$1.13 which represents a miss of analyst forecast a -$1.06 per share.

  • Is Revolution Medicines Profitable?

    Revolution Medicines reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Revolution Medicines EPS Next Year?

    Revolution Medicines's earnings are forecast to decrease from -$3.58 per share to -$3.43 per share next year representing a decrease of -29.95%.

  • When is Revolution Medicines's Earnings Date?

    Revolution Medicines's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Where Will CoreWeave Stock Be in 1 Year?
Where Will CoreWeave Stock Be in 1 Year?

When CoreWeave (NASDAQ: CRWV) slipped below its $40 IPO price…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock